$QS Cashflow Statement | Understand Stock

$QS

$4.18 +$0.28 (7.18%) Close

$QS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of right-of-use assets
Amortization of right-of-use assets and non-cash lease expense
Accretion of discounts on marketable securities
Stock-based compensation expense
Change in fair value of assumed common stock warrant liabilities
Write-off of property and equipment
Other
Changes in operating assets and liabilities:
Prepaid expenses and other current assets and other assets
Accounts payable, accrued liabilities and accrued compensation and benefits
Accrued compensation
Operating lease liability
Other liabilities

Net cash used in operating activities
Investing activities
Purchases of property and equipment
Proceeds from maturities of marketable securities
Proceeds from sales of marketable securities
Purchases of marketable securities
Other
Net cash (used in) provided by investing activities
Financing activities
Proceeds from exercise of stock options and employee stock purchase plan
Proceeds from issuance of common stock
Common stock issuance costs paid
Proceeds from exercise of warrants
Proceeds from issuance of Class A Common Stock pursuant to Legacy QuantumScape Series F Preferred Stock Purchase Agreement, net of issuance costs
Business Combination, net of issuance costs paid
Proceeds from finance lease, net of principal payment
Principal payment for finance lease
Cash received under collaboration agreement - related party
Dissolution of joint venture
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow information
Cash paid for interest
Fair value of assumed common stock warrants exercised
Purchases of property and equipment, not yet paid

Comments